The government of Burkina Faso has announced a massive price reduction for generic medications and medical supplies, with some costs falling by as much as 72% to improve public health access.
Following a cabinet meeting held on February 12, 2026, authorities confirmed a substantial decrease in the cost of essential generic drugs and specific health products. These supplies, which are managed and distributed by the Centrale d’achat des médicaments essentiels génériques (CAMEG), will see these new price adjustments take effect starting March 1, 2026.
Significant savings across various medical categories
According to the Minister of Health, Dr Robert Lucien Jean-Claude Kargougou, the price cuts vary depending on the type of medication. Patients will benefit from reductions of up to 67.27% for certain tablet forms, while injectable treatments will see a decrease of 53.47%. Furthermore, liquid medications such as syrups and suspensions will be reduced by 20%, and specific medical consumables will experience price drops reaching 72.73%.
State funding to ensure equitable healthcare
To facilitate this major reform, the state is mobilizing a financial support package estimated at 3 billion FCFA. This initiative is designed to alleviate the financial burden of medical expenses on local households, improve overall treatment availability, and foster greater equity within the national healthcare system.
This latest move follows a previous price reduction initiative in May 2025, which had a budgetary impact of nearly 5 billion FCFA. These consecutive measures highlight the ongoing dedication of the Burkina Faso administration to providing high-quality, affordable medical care to all its citizens.
